Back to results
US 2008/0188457 A1Published application
Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
AssigneeBrainCells, Inc.
InventorsCarrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
Life of this patent
Estimating the term…
Abstract
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of one or more biguanides in combination with one or more GSK3-β agents, to stimulate or activate the formation of new nerve cells.
Claims34
A composition comprising one or more biguanides in combination with one or more GSK3-β agents.
Dependencies are inferred from the claim text.